Note 13 - Segment Information

12 Months Ended

Jun. 30, 2017

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note

1

3

.

Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with

GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into

three

reportable segments as follows:

Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the fiscal years ended

June 30, 2017

and

2016

were

$9,283

and

$7,901,

respectively.

Financial information relating to the fiscal years ended

June 30, 2017

and

2016

operations by business segment are as follows:

								Segment
		Sales, Net						Gross
		U.S.		International				Profit					Capital		Total
		Customers		Customers		Total		(Loss)			Depreciation		Expenditures		Assets
Contract	2017	$	36,176	$	8,926	$	45,102	$	6,174		$	290	$	319	$	12,134
Manufacturing	2016		32,480		7,457		39,937		4,854			244		439		11,761
Branded Proprietary	2017		169		216		385		(53	)		-		-		784
Products	2016		330		339		669		73			-		-		676
Other Nutraceutical	2017		1,326		141		1,467		546			2		8		2,278
Businesses	2016		1,503		105		1,608		577			2		1		1,512
Total	2017		37,671		9,283		46,954		6,667			292		327		15,196
Company	2016		34,313		7,901		42,214		5,504			246		440		13,949